US to purchase a further 100 million COVID vaccine doses from Pfizer

An unknown source close to the deal has said that the U.S. government is very close to finalizing a purchase of 100 million coronavirus vaccine doses from Pfizer.

A source told CNBC's Meg Tirrell on Tuesday that the new deal between Pfizer and the U.S. government could be announced this Wednesday. Pfizer was asked if this news was true and declined to comment, saying the company "is not able to comment on any confidential discussions that may be taking place with the U.S. government."

The CEO of Pfizer, Dr. Albert Bourla, said last week that the company was currently involved with negotiations with the federal government regarding a purchase of 100 million COVID-19 vaccine doses for next year. In an interview on December 14th, Dr. Bourla said that the U.S. government and Pfizer were ironing out the details about when those vaccine doses can arrive by. Pfizer has said that they can provide the doses by the third quarter of 2021, but the U.S. government is pushing for the second quarter of 2021.

Dr. Bourla said, "We are working very collaboratively to try to find a solution and be able to allocate those 100 million [doses] in the second quarter if possible or a lot of them."

For more information on this story, check out this link here.